Literature DB >> 21099667

Genotypic tropism testing: evidence-based or leap of faith?

P Richard Harrigan, Anna Maria Geretti.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21099667     DOI： 10.1097/QAD.0b013e32834113f9

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  12 in total

1.  Correlation of the virological response to short-term maraviroc monotherapy with standard and deep-sequencing-based genotypic tropism prediction methods.

Authors:  A Gonzalez-Serna; R A McGovern; P R Harrigan; F Vidal; A F Y Poon; S Ferrando-Martinez; M A Abad; M Genebat; M Leal; E Ruiz-Mateos
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Genotypic prediction of human immunodeficiency virus type 1 tropism by use of plasma and peripheral blood mononuclear cells in the routine clinical laboratory.

Authors:  Christian Paar; Maria Geit; Herbert Stekel; Jörg Berg
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

3.  HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.

Authors:  Cécile Tremblay; Isabelle Hardy; Richard Lalonde; Benoit Trottier; Irina Tsarevsky; Louis-Philippe Vézina; Michel Roger; Mark Wainberg; Jean-Guy Baril
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

4.  Validation of the HIV Tropism Test TROCAI Using the Virological Response to a Short-Term Maraviroc Monotherapy Exposure.

Authors:  A Gonzalez-Serna; M Genebat; M De Luna-Romero; L Tarancon-Diez; B Dominguez-Molina; Y M Pacheco; M A Muñoz-Fernández; M Leal; E Ruiz-Mateos
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia.

Authors:  Lavinia Fabeni; Giulia Berno; Valentina Svicher; Francesca Ceccherini-Silberstein; Caterina Gori; Ada Bertoli; Cristina Mussini; Miriam Lichtner; Mauro Zaccarelli; Adriana Ammassari; Carmela Pinnetti; Stefania Cicalini; Claudio Maria Mastroianni; Massimo Andreoni; Andrea Antinori; Carlo Federico Perno; Maria Mercedes Santoro
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

6.  Comparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of Cenicriviroc Study 202, a randomized phase II trial in treatment-naive subjects.

Authors:  Ron M Kagan; Erik P Johnson; Martin F Siaw; Ben Van Baelen; Richard Ogden; Jamie L Platt; Rick L Pesano; Eric Lefebvre
Journal:  AIDS Res Hum Retroviruses       Date:  2013-08-14       Impact factor: 2.205

7.  A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patients.

Authors:  Ron M Kagan; Erik P Johnson; Martin Siaw; Pinaki Biswas; Douglass S Chapman; Zhaohui Su; Jamie L Platt; Rick L Pesano
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

8.  Clustering of HIV-1 Subtypes Based on gp120 V3 Loop electrostatic properties.

Authors:  Aliana López de Victoria; Chris A Kieslich; Apostolos K Rizos; Elias Krambovitis; Dimitrios Morikis
Journal:  BMC Biophys       Date:  2012-02-07       Impact factor: 4.778

9.  Development of a rapid cell-fusion-based phenotypic HIV-1 tropism assay.

Authors:  Phairote Teeranaipong; Noriaki Hosoya; Ai Kawana-Tachikawa; Takeshi Fujii; Tomohiko Koibuchi; Hitomi Nakamura; Michiko Koga; Naoyuki Kondo; George F Gao; Hiroo Hoshino; Zene Matsuda; Aikichi Iwamoto
Journal:  J Int AIDS Soc       Date:  2013-09-18       Impact factor: 5.396

10.  HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].

Authors:  Martin Mulinge; Morgane Lemaire; Jean-Yves Servais; Arkadiusz Rybicki; Daniel Struck; Eveline Santos da Silva; Chris Verhofstede; Yolanda Lie; Carole Seguin-Devaux; Jean-Claude Schmit; Danielle Perez Bercoff
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.